Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

AIDS therapy organelles

A technology of organelles and AIDS, applied in the direction of suction equipment, blood circulation treatment, etc., can solve the problems of high toxicity and side effects, lack of immunity to kill HIV, poor efficacy of drugs, etc.

Active Publication Date: 2018-12-04
翁炳焕 +1
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] The human body lacks the immunity to kill HIV, and the drugs used in the body have poor curative effect and severe side effects. AIDS is a worldwide problem that cannot be overcome for a long time.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • AIDS therapy organelles
  • AIDS therapy organelles
  • AIDS therapy organelles

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0015] figure 1 It is a schematic diagram of the application of the AIDS therapeutic organelle proposed according to the present invention.

[0016] figure 2 It is the internal structure diagram of the plasma separator proposed according to the present invention.

[0017] image 3 It is a diagram of the internal structure of the AIDS therapy organelle proposed according to the present invention.

[0018] figure 1 Among them, one end of the arterial blood line tube (1) is connected with the arterial blood vessel, and the other end is connected with the plasma separator (4) through the heparin pump (2) and the blood pump (3), and the plasma separator (4) is connected through the plasma pump (6) ) and the circulation line (7) are connected with two parallel organelles (8) and organelles (9), and then connected with the circulation line (10) and the venous line (5) in turn, and the other of the venous line (5) One end is connected to the vein blood vessel.

[0019] figure...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to AIDS treatment organelle in the field of biomedicine. The AIDS treatment organelle is characterized in that CD14 cells are separated out through a magnetic activated cell sorting method so as to prepare a hybridoma macrophage cell line with characteristics of original macrophage cells retained and supportive of indeterminate growth; clone having high phagocytosis on HIV is selected for multiplication culture and storage; the hybridoma macrophage cell line prepared thereby is wrapped with a high-biocompatibility material to prepare organelle capable of preventing cells and debris thereof and even the HIV from being filtered out and capable of providing a place for the organelle to devour HIV; the organelle and a serum separator form in-vitro circulation; after separated serum is filtered out by the organelle, HIV therein is devoured and eliminated by the macrophage cell line, and anti-infection macrophage cell factors generated at the same time are transported back into body along with the serum. In this way, an AIDS hybridoma technology in-vitro novel treatment method capable of eliminating the HIV and supplementing needed macrophage cell factors is realized, and is more feasible while being free of toxic and side effect when compared with conventional treatment methods which are limited to kill the HIV in vivo and are difficult to realize.

Description

technical field [0001] The invention relates to organelles for treating AIDS in the field of biomedicine. The HIV-sensitive cells are mainly prepared by artificial industry and used to phagocytize free HIV in plasma in vitro to achieve the purpose of treating AIDS. Background technique [0002] AIDS is an infectious disease caused by human immunodeficiency virus (Human Immunodeficiency Virus, HIV). So far, 208 countries and regions in the world have been seriously threatened by AIDS. About 40 million people have been infected with AIDS, and the death toll has exceeded 20 million. About 6,000 people become AIDS-infected people every day, and more than 300 people die every day. on AIDS. HIV-infected people in China are in a period of rapid growth, and the number has far exceeded 1 million at present. AIDS has become another major infectious disease facing mankind after tumors, cardiovascular and cerebrovascular diseases, tuberculosis, and diabetes, and has become a serious p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61M1/36
CPCA61M1/3692
Inventor 翁炳焕李兰娟潘小平徐威许亚丽
Owner 翁炳焕
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com